Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPIRI.L Regulatory News (PIRI)

  • There is currently no data for PIRI

Director/PDMR Shareholding

9 Sep 2013 13:47

RNS Number : 5371N
Pires Investments PLC
09 September 2013
 



 

Pires InvestmentsPLC

("Pires" or the "Company")

Director's Dealing

 

C J Yates, a director of the Company, advised the Company on 6 September 2013 that he purchased, through his SIPP, 4,840,656 ordinary shares of £0.001 each in the Company on 23 August 2013. Following the acquisition Mr Yates is beneficially interested in 6,766,819 ordinary shares, representing 0.29% of the Company's issued ordinary share capital.

The Company's issued ordinary share capital consists of 2,321,659,864 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in Pires under the Transparency (Directive 2004/109/EC) Regulation 2007 and the Rules of the UK Financial Conduct Authority.

For further information, please visit http://www.piresinvestments.com or contact:

Pires Investments PLC

Peter Redmond, Director

 

Tel: 020 7580 7576

 

Nominated Adviser

Cairn Financial Advisers LLP

Liam Murray/Avi Robinson

 

Tel: 020 7148 7900

 

Broker

Peterhouse Corporate Finance

Jon Levinson

Lucy Williams

 

Tel: 020 7469 0935

Tel: 020 7469 0936

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSMFEUFDSELU
Date   Source Headline
27th Jan 20217:00 amRNSExercise of Warrants
25th Jan 20217:00 amRNSNew SVV Investment in Virtex VR
21st Jan 20217:00 amRNSExercise of Warrants
19th Jan 20212:05 pmRNSSecond Price Monitoring Extn
19th Jan 20212:00 pmRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSHolding(s) in Company
15th Jan 20217:00 amRNSCompletion of investment in decentralised finance
15th Jan 20217:00 amRNSExercise of Warrants
14th Jan 20212:10 pmRNSHolding(s) in Company
12th Jan 20212:00 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSCameraMatics raises EUR4m in Series A funding
8th Jan 20219:46 amRNSHolding(s) in Company
7th Jan 202112:16 pmRNSExercise of Warrant
7th Jan 202111:38 amRNSAppointment of Broker
4th Jan 202110:39 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
29th Dec 20209:47 amRNSHolding(s) in Company
14th Dec 20207:00 amRNSInvestment in Low6
2nd Dec 202011:31 amRNSInvestment in decentralised finance
21st Oct 20207:00 amRNSChange of accounting reference date
6th Oct 202012:40 pmRNSVRE Update
6th Oct 20207:00 amRNSBuymie partners with Dunnes Stores
2nd Oct 20207:00 amRNSAmbisense launches new COVID-19 platform AmbiAir
1st Oct 20208:30 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdmix fundraise
21st Sep 20201:00 pmRNSHolding(s) in Company
17th Sep 20207:00 amRNSVividQ Update
16th Sep 20207:00 amRNSExercise of Warrant
4th Sep 202012:26 pmRNSHolding(s) in Company
2nd Sep 20204:54 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNSExercise of Warrant
28th Aug 20209:57 amRNSHolding(s) in Company
17th Aug 20209:15 amRNSHolding(s) in Company
12th Aug 202010:40 amRNSHolding(s) in Company
11th Aug 20207:00 amRNSGetvisibility signs distribution agreement
31st Jul 20207:00 amRNSHalf-year Report
29th Jul 202012:19 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSNew SVV investment in Volograms Limited
20th Jul 20209:10 amRNSHolding(s) in Company
10th Jul 20207:00 amRNSAppointment of Joint Broker
3rd Jul 202012:09 pmRNSHolding(s) in Company
1st Jul 20202:36 pmRNSUpdate re portfolio companies
30th Jun 20204:11 pmRNSTotal Voting Rights
26th Jun 20207:02 amRNSGetvisibility video interview
25th Jun 20207:00 amRNSInvestor Presentation
24th Jun 20201:30 pmRNSResult of AGM
22nd Jun 20207:02 amRNSBroadcast Interview with Share Talk
22nd Jun 20207:00 amRNSPartial sale of shareholding in VR Education
15th Jun 20207:00 amRNSBuymie fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.